Faculty Opinions recommendation of Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.

Double Blind Placebo ◽

Faculty Opinions recommendation of Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717847851.793352803 ◽

2012 ◽

Author(s):

David Murdoch

Keyword(s):

Monoclonal Antibody ◽

Pseudomonas Aeruginosa ◽

Controlled Trial ◽

Antibody Fragment ◽

Double Blind ◽

Mechanically Ventilated ◽

Double Blind Placebo ◽

Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa

Critical Care Medicine ◽

10.1097/ccm.0b013e31825334f6 ◽

2012 ◽

Vol 40 (8) ◽

pp. 2320-2326 ◽

Cited By ~ 97

Author(s):

Bruno François ◽

Charles-Edouard Luyt ◽

Anthony Dugard ◽

Michel Wolff ◽

Jean-Luc Diehl ◽

...

Keyword(s):

Monoclonal Antibody ◽

Pseudomonas Aeruginosa ◽

Antibody Fragment ◽

Mechanically Ventilated ◽

A Randomized Double-Blind Placebo-Controlled Dose-Escalation Phase 1 Study of Aerosolized Amikacin and Fosfomycin Delivered via the PARI Investigational eFlow® Inline Nebulizer System in Mechanically Ventilated Patients

Journal of Aerosol Medicine and Pulmonary Drug Delivery ◽

10.1089/jamp.2013.1100 ◽

2014 ◽

Vol 27 (6) ◽

pp. 441-448 ◽

Cited By ~ 45

Author(s):

A. Bruce Montgomery ◽

Shirley Vallance ◽

Tammy Abuan ◽

Markus Tservistas ◽

Andrew Davies

Keyword(s):

Dose Escalation ◽

Phase 1 ◽

Phase 1 Study ◽

Double Blind ◽

Mechanically Ventilated ◽

Double Blind Placebo ◽

Faculty Opinions recommendation of Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1108987.566149 ◽

2008 ◽

Author(s):

Johann Gudjonsson

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Anti-interleukin-17A monoclonal antibody secukinumab in treatment of ankylosing spondylitis: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718110070.793498413 ◽

2014 ◽

Author(s):

David Daikh

Keyword(s):

Monoclonal Antibody ◽

Ankylosing Spondylitis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 17A

Faculty Opinions recommendation of Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725764423.793519827 ◽

2016 ◽

Author(s):

Taka-aki Nakada

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Mechanically Ventilated ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Faculty Opinions recommendation of Conservative versus Liberal Oxygenation Targets for Mechanically Ventilated Patients. A Pilot Multicenter Randomized Controlled Trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725764423.793513258 ◽

2016 ◽

Author(s):

Jesús Villar

Keyword(s):

Randomized Controlled Trial ◽

Controlled Trial ◽

Mechanically Ventilated ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Family automated voice reorientation (FAVoR) intervention for mechanically ventilated patients in the intensive care unit: Study protocol for a randomized controlled trial

Contemporary Clinical Trials ◽

10.1016/j.cct.2021.106277 ◽

2021 ◽

Vol 102 ◽

pp. 106277

Author(s):

Cindy L. Munro ◽

Zhan Liang ◽

Ming Ji ◽

Maya N. Elías ◽

Xusheng Chen ◽

...

Keyword(s):

Intensive Care Unit ◽

Randomized Controlled Trial ◽

Intensive Care ◽

Study Protocol ◽

Controlled Trial ◽

Mechanically Ventilated ◽

Randomized Controlled ◽

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ANTI-INTERLEUKIN-13 MONOCLONAL ANTIBODY RPC4046 IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS

Annals of Allergy Asthma & Immunology ◽

10.1016/j.anai.2018.09.047 ◽

2018 ◽

Vol 121 (5) ◽

pp. S15

Author(s):

I. Hirano ◽

M. Collins ◽

Y. Assouline-Dayan ◽

L. Evans ◽

S. Gupta ◽

...

Keyword(s):

Monoclonal Antibody ◽

Eosinophilic Esophagitis ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 13

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

The Lancet ◽

10.1016/s0140-6736(08)60726-6 ◽

2008 ◽

Vol 371 (9625) ◽

pp. 1675-1684 ◽

Cited By ~ 970

Author(s):

Kim A Papp ◽

Richard G Langley ◽

Mark Lebwohl ◽

Gerald G Krueger ◽

Philippe Szapary ◽

...

Keyword(s):

Monoclonal Antibody ◽

Controlled Trial ◽

Interleukin 12 ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo